Larson Financial Group LLC Harmony Biosciences Holdings, Inc. Transaction History
Larson Financial Group LLC
- $1.75 Billion
- Q3 2024
A detailed history of Larson Financial Group LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 4 shares of HRMY stock, worth $155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$155
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
247Shares Held
45.7MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$437 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$227 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$135 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$102 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.9 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...